31 min listen
A closer look at 'friend-shoring' and the drug shortage challenge
FromThe Top Line
ratings:
Length:
18 minutes
Released:
Jun 21, 2024
Format:
Podcast episode
Description
In this week’s episode of “The Top Line,” Fierce Pharma’s Zoey Becker sits down with Bobby Sheng, the CEO of Bora Pharmaceuticals, to discuss the concept of “friend-shoring” in drug manufacturing.
"Friend-shoring" involves conducting manufacturing processes in countries considered friendly or allied. Sheng discusses the criteria for deeming a country “friendly” and explores whether this strategy could help address drug supply shortages.
To learn more about the topics in this episode:
Bora plants its flag in the US with $210M acquisition of generics manufacturer Upsher-Smith
Emergent, pivoting away from CDMO business, sells Baltimore plant to acquisitive Bora for $30M
See omnystudio.com/listener for privacy information.
"Friend-shoring" involves conducting manufacturing processes in countries considered friendly or allied. Sheng discusses the criteria for deeming a country “friendly” and explores whether this strategy could help address drug supply shortages.
To learn more about the topics in this episode:
Bora plants its flag in the US with $210M acquisition of generics manufacturer Upsher-Smith
Emergent, pivoting away from CDMO business, sells Baltimore plant to acquisitive Bora for $30M
See omnystudio.com/listener for privacy information.
Released:
Jun 21, 2024
Format:
Podcast episode
Titles in the series (99)
October 6th, 2022 by The Top Line